#National Cancer Institute

Up to $266 million to be moved from a number of health programs. Here’s how you can help stop it.

The researchers hope to develop a clinical trial to combine arsenic with the standard therapy for women with triple-negative breast cancer.

Using molecular tests to select the most appropriate treatment leads to better outcomes.

Jamie Troil Goldfarb, 40, is a patient advocate and works in public relations. She lives in Takoma Park, Maryland, with her husband and son.

Researchers concluded that “increased awareness and better early detection may improve endometrial cancer mortality going forward.”

Forty-five years since its launch, SEER can become an invaluable resource for performing and informing clinical and even basic research.

Researchers call the association of circulating tumor cells in blood with late recurrence of breast cancer “a really important observation.”

Bipartisan bill includes $190 million increase for National Cancer Institute.

Dietary or drug interventions could counteract resistance to PI3K inhibitors in many tumors.

The CALM program “intervenes proactively rather than just waiting for people to get distressed, anxious, depressed, and overwhelmed.”

IMPRES score identified nearly all patients who responded to checkpoint inhibitors and more than half of those who did not.

This finding could lead to clinical trials specifically for men with treatment-emergent small-cell neuroendocrine prostate cancer.

A conversation with Magdalena Thurin, PhD, and Helen Chen, MD

Researchers say results could help develop treatments not just for chemotherapy-induced diarrhea, but for other bowel disorders as well.

A conversation with Judith Paice of the Cancer Pain Program at Northwestern University’s Feinberg School of Medicine.

In the study, the antioxidant made children less likely to permanently lose hearing without affecting their chemotherapy treatment.